It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
SOPH’s FA Score shows that 0 FA rating(s) are green whileVSEE’s FA Score has 1 green FA rating(s).
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
SOPH’s TA Score shows that 5 TA indicator(s) are bullish while VSEE’s TA Score has 3 bullish TA indicator(s).
SOPH (@Services to the Health Industry) experienced а +6.59% price change this week, while VSEE (@Services to the Health Industry) price change was -1.71% for the same time period.
The average weekly price growth across all stocks in the @Services to the Health Industry industry was -1.92%. For the same industry, the average monthly price growth was -1.20%, and the average quarterly price growth was -13.16%.
SOPH is expected to report earnings on Aug 11, 2026.
This industry comprises companies that provide services, such as equipment sterilization, research, physician management systems and consulting, that support the healthcare/medical industry. Examples of such companies include Laboratory Corporation of America Holdings, which operates one of the largest clinical laboratory networks in the world; Quest Diagnostics Inc., which is a clinical laboratory; and Syneos Health, which is a major clinical research organization.
| SOPH | VSEE | SOPH / VSEE | |
| Capitalization | 448M | 5.86M | 7,644% |
| EBITDA | -64.13M | -8.45M | 759% |
| Gain YTD | 14.347 | -67.788 | -21% |
| P/E Ratio | N/A | 0.54 | - |
| Revenue | 81.2M | 14.5M | 560% |
| Total Cash | 65.4M | 1.35M | 4,859% |
| Total Debt | 62.4M | 2.14M | 2,923% |
| SOPH | VSEE | |
|---|---|---|
| RSI ODDS (%) | N/A | 2 days ago 83% |
| Stochastic ODDS (%) | 2 days ago 90% | 2 days ago 52% |
| Momentum ODDS (%) | 2 days ago 89% | 2 days ago 51% |
| MACD ODDS (%) | 2 days ago 87% | 2 days ago 38% |
| TrendWeek ODDS (%) | 2 days ago 85% | 2 days ago 65% |
| TrendMonth ODDS (%) | 2 days ago 85% | 2 days ago 72% |
| Advances ODDS (%) | 6 days ago 82% | 28 days ago 69% |
| Declines ODDS (%) | 12 days ago 85% | 6 days ago 83% |
| BollingerBands ODDS (%) | 2 days ago 90% | 2 days ago 30% |
| Aroon ODDS (%) | N/A | 2 days ago 90% |
| 1 Day | |||
|---|---|---|---|
| MFs / NAME | Price $ | Chg $ | Chg % |
| SEKIX | 31.24 | N/A | N/A |
| DWS Emerging Markets Equity Inst | |||
| CSRYX | 47.63 | N/A | N/A |
| Columbia Select Large Cap Value Inst3 | |||
| PDEZX | 26.82 | N/A | N/A |
| PGIM Jennison Emerging Markets Eq Opps Z | |||
| JGTTX | 40.49 | N/A | N/A |
| JPMorgan Growth Advantage R3 | |||
| HWLZX | 47.22 | N/A | N/A |
| Hotchkis & Wiley Large Cap Fdml Value Z | |||
A.I.dvisor tells us that VSEE and CTEV have been poorly correlated (+21% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that VSEE and CTEV's prices will move in lockstep.
| Ticker / NAME | Correlation To VSEE | 1D Price Change % | ||
|---|---|---|---|---|
| VSEE | 100% | +4.33% | ||
| CTEV - VSEE | 21% Poorly correlated | -3.33% | ||
| AMWL - VSEE | 21% Poorly correlated | -2.49% | ||
| BEAT - VSEE | 20% Poorly correlated | -6.52% | ||
| WEAV - VSEE | 20% Poorly correlated | -0.77% | ||
| SOPH - VSEE | 20% Poorly correlated | -2.20% | ||
More | ||||